Biomarkers & Diagnostics World Congress 2016 | MedGenome
Toll Free Number: 1800 103 3691
Hours: 8:00 AM - 8:00 PM, Monday to Saturday
Closed on public holidays and Sundays

Biomarkers & Diagnostics World Congress 2016

Biomarkers & Diagnostics World Congress 2016

Cancer immunotherapy has made extraordinary progress both conceptually and in clinical practice. The recent FDA approval of drugs in this area has paved the way for many upcoming independent and combination therapies in the immuno-oncology segment.

A variety of strategies are continuing to evolve in the laboratory and in the clinic, including cancer vaccines, T cells, and immune checkpoint blockade. Despite their promise, much more research is needed to understand how and why certain cancers fail to respond to immunotherapy and to predict which therapeutic strategies, or combinations thereof, are most appropriate for each patient.

Related Articles

Test Menu

Genetic Counselling

Microsites

Collaterals

Contact Us